BioSpace News Archive

Medidata, a Dassault Systèmes company, today announced that Launch Therapeutics selected Medidata AI Intelligent Trials to support its innovative approach to accelerating clinical trials of late-stage therapies.

Alamar Biosciences, a company powering precision proteomics to enable the earliest detection of disease, announced the unveiling of its technology platform NULISA™, a novel automated ultrasensitive and highly multiplexed proteomics technology for liquid biopsy.

GeneCentric Therapeutics, a company making precision medicine more precise through RNA-based diagnostics, today announced the appointment of Brian Kelly as Senior Vice President of Business Development.

Sivananthan Laboratories Inc., a high-tech business incubator and a national leader in the infrared sensing and imaging industry, announced the successful completion of a $1.5M award from the Small Business Technology Transfer Phase II program for the development of an entangled short-wavelength infrared photon source.

IntraBio Inc announced it completed and closed its $15 Million Series C funding round on April 5, 2023.

Neocis®, manufacturer of Yomi® and the global leader in robot-assisted dental surgery, announced the official market launch of the platform’s bone reduction module.

Nova Eye Medical Limited (ASX: EYE) (Nova Eye Medical or the Company) today announces that it has been granted U.S. Food and Drug Administration (FDA) 510(k) clearance for its new canaloplasty device, iTrack™ Advance.

Initial offerings focus on high-content imaging and digital PCR Agathos Biologics, a leading biotechnology company, is proud to offer advanced analytical testing services for life science researchers.

Gestalt Diagnostics Inc. and ARUP Laboratories announced that ARUP has selected Gestalt’s award-winning PathFlow® digital platform as the solution to support its comprehensive vision for digital pathology.

AB Science SA announced that Professor Albert Ludolph, MD, PhD, will deliver a presentation on masitinib in amyotrophic lateral sclerosis to an audience of key opinion leaders in the field of ALS healthcare, at the up-coming American Academy of Neurology 2023 Annual Meeting in Boston, USA.